文献速递腹部技术与安全USMR

Sonazoid超声造影与Gd-EOB-DTPA增强MRI预测肝细胞癌微血管侵犯的比较

Comparison of Sonazoid-Contrast‑Enhanced Ultrasound and Gd‑EOB‑DTPA‑Enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
PubMed 文献 · Ultrasound Med Biol · 2024-05-31

该单中心前瞻性研究纳入64例经病理证实为单发肝细胞癌的患者,其中21例有微血管侵犯、43例无微血管侵犯,比较Sonazoid超声造影与Gd-EOB-DTPA增强MRI预测微血管侵犯的诊断效能。多因素分析显示,超声特征(肿瘤大小>4.35 cm、瘤周增强、血管后环状增强、动脉期峰值能量差<-1.0×10^6 a.u)与MRI特征(环状增强、肿瘤边缘不规则、晕征)均为独立预测因子(p<0.05)。两种方法的AUC无统计学显著差异(p>0.05);超声造影敏感度较高,MRI特异度较高。

要点

  • 超声造影预测MVI的敏感度61.9%–86.4%、特异度42.9%–71.4%,动脉期峰值能量差的敏感度最高(86.4%)。
  • MRI预测MVI的敏感度33.3%–76.3%、特异度54.7%–90.5%,晕征特异度最高(90.5%)。
  • 超声与MRI预测MVI的AUC无统计学显著差异(p>0.05)。

核心结论

  • Sonazoid超声造影和Gd-EOB-DTPA增强MRI均显示出预测肝细胞癌微血管侵犯的潜力;超声造影敏感度较高,MRI特异度较高。

研究设计与样本

  • 单中心前瞻性研究,纳入64例经组织病理学证实的单发肝细胞癌病灶患者;按术后病理分为有微血管侵犯组(n=21)和无微血管侵犯组(n=43);比较Sonazoid超声造影与Gd-EOB-DTPA增强MRI预测微血管侵犯的诊断效能。

关键影像表现/征象

  • 超声特征中,肿瘤大小>4.35 cm、瘤周增强、血管后环状增强、动脉期肿瘤边缘区与远端肝实质差异的峰值能量<-1.0×10^6 a.u均为MVI的独立预测因子(p<0.05)。
  • MRI特征中,环状增强、肿瘤边缘不规则和晕征均为MVI的独立预测因子(p<0.05)。
  • 超声造影特征预测MVI的敏感度为61.9%–86.4%,特异度为42.9%–71.4%。
  • MRI特征预测MVI的敏感度为33.3%–76.3%,特异度为54.7%–90.5%。
  • 动脉期峰值能量差(肿瘤边缘区与远端肝实质差异)的敏感度最高,为86.4%;MRI晕征的特异度最高,为90.5%。

诊断标准与关键数值

  • 超声造影预测MVI的敏感度61.9%–86.4%、特异度42.9%–71.4%。
  • MRI预测MVI的敏感度33.3%–76.3%、特异度54.7%–90.5%。
  • 超声与MRI预测MVI的AUC比较无统计学显著差异(p>0.05)。
  • 超声独立预测因子:肿瘤大小>4.35 cm、瘤周增强、血管后环状增强、动脉期峰值能量差<-1.0×10^6 a.u(p<0.05)。
  • MRI独立预测因子:环状增强、肿瘤边缘不规则、晕征(p<0.05)。

临床应用与阅片要点

  • 动脉期峰值能量差(肿瘤边缘区与远端肝实质差异)敏感度最高(86.4%),可作为超声造影提示MVI的参考指标。
  • MRI晕征特异度最高(90.5%),有助于提高MVI诊断的特异性。
  • 超声造影与MRI预测MVI的AUC无统计学显著差异(p>0.05),两者诊断效能相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aims to evaluate and compare the predictive accuracy of Sonazoid-contrast-enhanced ultrasound (CEUS) and Gd-EOB-DTPA-enhanced MRI for detecting microvascular invasion (MVI) in hepatocellular carcinoma (HCC).

METHODS: In this single-center prospective study, we included 64 patients with histopathologically confirmed single HCC lesions. Based on post-operative pathologic data, patients were categorized into two groups: those with MVI (n = 21) and those without MVI (n = 43). The diagnostic efficacy of CEUS was compared with that of MRI in predicting MVI.

RESULTS: Multifactorial analysis revealed that US features (tumor size > 4.35 cm, peritumoral enhancement, post-vascular ring enhancement, peak energy in the arterial phase of the difference between the margin area of HCC and distal liver parenchyma <-1.0 × 106 a.u), MRI features (rim enhancement, irregular tumor margin, and the halo sign) were all independent predictors of MVI (p < 0.05). The sensitivity and specificity of CEUS features in predicting MVI ranged from 61.9% to 86.4% and from 42.9% to 71.4%, respectively. For MRI features, the sensitivity and specificity ranged from 33.3% to 76.3% and from 54.7% to 90.5%, respectively. No statistically significant differences were observed in the area under the curve between CEUS and MRI (p > 0.05). Notably, peak energy of the difference showed the highest sensitivity at 86.4%, while the halo sign in MRI exhibited the highest specificity at 90.5%.

CONCLUSION: Sonazoid-CEUS and Gd-EOB-DTPA-enhanced MRI demonstrate potential in predicting MVI in HCC lesions. Notably, CEUS showed higher sensitivity, whereas MRI displayed greater specificity in predicting MVI.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Huang Z, Zhu RH, Li SS, et al. Comparison of Sonazoid-Contrast‑Enhanced Ultrasound and Gd‑EOB‑DTPA‑Enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma. Ultrasound Med Biol. 2024. PMID: 38824054. doi:10.1016/j.ultrasmedbio.2024.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。